Aprea Therapeutics Announces Removal of FDA Clinical Hold on Eprenetapopt
09 Dec 2021 //
GLOBENEWSWIRE
Aprea Therapeutics Presents Data From Phase 1/2 Trial of Eprenetapopt (APR-246)
20 Sep 2021 //
GLOBENEWSWIRE
09 Dec 2021 //
GLOBENEWSWIRE
20 Sep 2021 //
GLOBENEWSWIRE